TOMOCUBE, INC.
See your samples like never before with Tomocube’s revolutionary label-free, live cell Holotomography
Founded 2015
Korea South
57 employees
Series C
Total: $26.20B
Biotechnology, Health Care
Korea South
57 employees
Series C
Total: $26.20B
Biotechnology, Health Care
General Information
Company Name
TOMOCUBE, INC.
Founded Year
2015
Location
Korea South
Korea South
Employees
57
Industries
Biotechnology, Health Care
Funding Stage
Series C
BounceWatch is an independent company data service, not affiliated with TOMOCUBE, INC.. To contact TOMOCUBE, INC., visit tomocube.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does TOMOCUBE, INC. compare?
A PDF of TOMOCUBE, INC. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting TOMOCUBE, INC. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Korea South Market
Biotechnology
About TOMOCUBE, INC.
Business keywords: Holotomography, 3D imaging, Biological research, Medical research, Optical solutions, Live cell imaging, Label-free imaging, Cell analysis, AI-driven analysis, Nanoscale imaging, Dynamic imaging, Subcellular organelles, Phenotypic analysis, Data analysis software, Tomocube
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | KRW21.20B | 8 |
|
23 Sep 2021 |
| Venture Round | Undisclosed | 1 |
STIC Ventures
|
01 Aug 2019 |
| Series C | Undisclosed | 1 |
|
01 Jan 2019 |
| Venture Round | KRW5.00B | - |
|
10 Apr 2018 |
| Venture Round | Undisclosed | - |
|
01 Jan 2017 |
TOMOCUBE, INC. Alternatives & Competitors
View All Alternatives
TOMOCUBE, INC. vs
LumaCyte
United States
Transforming the status quo through rapid label-free single cell analysis
Series B
25 employees
Biotechnology, Health Care
TOMOCUBE, INC. vs
Phasefocus
United Kingdom
Label-free high-content live cell assays from 96-wells to single cells.
Venture round
11 employees
Biotechnology, Health Care
TOMOCUBE, INC. vs
Vizgen
United States
Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial...
Series E
153 employees
Biotechnology, Health Care
FAQ About TOMOCUBE, INC.
See your samples like never before with Tomocube’s revolutionary label-free, live cell Holotomography
TOMOCUBE, INC. was founded in 2015.
TOMOCUBE, INC. is headquartered in Korea South.
TOMOCUBE, INC. operates in Biotechnology and Health Care. Its work centres on Holotomography, 3D imaging, Biological research and Medical research.
TOMOCUBE, INC. has approximately 57 employees.
TOMOCUBE, INC. has completed 5 funding rounds, raising a total of $26.20B. The latest funding stage is Series C.
Top alternatives and competitors to TOMOCUBE, INC. include LumaCyte, Phasefocus, Vizgen, Celldom, Inc., LevitasBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TOMOCUBE, INC. and LumaCyte are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for TOMOCUBE, INC., https://bouncewatch.com/company/tomocube-inc, updated 25 November 2024. When citing, please name BounceWatch and link this page.
